Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
ALXN1210-MG-306: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis
Mahuwala, Zabeen
(PI)
Neurology
Neuroscience Research Priority Area
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
12/20/19
→
11/13/20
Funding
Syneos Health LLC:
$11,825.00
View all
View less